Stacey Bain

Director/Board Member at

Catalyst Canada, Inc.

Health Technology

Consumer Services

Commercial Services

Profile

Stacey Bain is currently a Director at Catalyst Canada, Inc. Prior to this, she held positions as Vice President-Clinical Product Development at BioNumerik Pharmaceuticals, Inc. and Vice President-Clinical Operations at Acer Therapeutics, Inc. She received a doctorate degree from Texas A&M University in 1998 and an undergraduate degree from the same institution in 1992.

Stacey Bain active positions

Companies	Position	Start
Catalyst Canada, Inc. Catalyst Canada, Inc. Advertising/Marketing ServicesCommercial Services Provides marketing and advertising services	Director/Board Member	-

All active positions of Stacey Bain

Former positions of Stacey Bain

Companies	Position	End
ACER THERAPEUTICS INC.	Chief Tech/Sci/R&D Officer	-
BioNumerik Pharmaceuticals, Inc. BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new medicines for cancer treatment	Corporate Officer/Principal	-

See the detail of Stacey Bain's experience

Training of Stacey Bain

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stacey Bain's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
BioNumerik Pharmaceuticals, Inc. BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new medicines for cancer treatment	Health Technology
Texas A&M University Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Catalyst Canada, Inc. Catalyst Canada, Inc. Advertising/Marketing ServicesCommercial Services Provides marketing and advertising services	Commercial Services
Acer Therapeutics, Inc. Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases	Health Technology